Cargando…
Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer
Many human cancers exhibit elevated prostaglandin (PG) levels due to upregulation of cyclooxygenase-2 (COX-2), a key enzyme in eicosanoid biosynthesis. COX-2 over-expression has been observed in about 40% of cases of invasive breast carcinoma and at a higher frequency in preinvasive ductal carcinoma...
Autor principal: | Howe, Louise R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206709/ https://www.ncbi.nlm.nih.gov/pubmed/17640394 http://dx.doi.org/10.1186/bcr1678 |
Ejemplares similares
-
Cyclooxygenase and Prostaglandin in Cancer
por: Kim, Jong-Woo
Publicado: (2012) -
Modulation of CXCR3 ligand secretion by prostaglandin E(2 )and cyclooxygenase inhibitors in human breast cancer
por: Bronger, Holger, et al.
Publicado: (2012) -
Renal Effects of Prostaglandins and Cyclooxygenase-2 Inhibitors
por: Kim, Gheun-Ho
Publicado: (2008) -
Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney
por: Nørregaard, Rikke, et al.
Publicado: (2015) -
Prostaglandins and prognosis in human breast cancer.
por: Watson, D. M., et al.
Publicado: (1987)